Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Filed Apr 3, 2025 · 10-K · 93 days after period end · 0001437749-25-010791
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$6.26M | -$9.72M | -$8.12M | -$3.68M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Apr 3, 2025 · 93 d after period end
